Abstract:OBJECTIVE:To develop an animal model of unstable atherosclerotic plaques.METHODS:Sixty-four New Zealand white rabbits were randomly divided into two groups: group A (n = 54, undergoing balloon-induced abdominal aortic wall injury and then fed on a diet of 1% cholesterol) and group B (n = 10, fed on a diet of 1% cholesterol only). At the end of the eighth week, the rabbits in group A were randomly divided into two subgroups: group A1 (n = 27) and group A2 (n = 27). Recombinant adenovirus carrying human wild-type p53 gene and beta galactosidase (LacZ) genes were injected through a catheter into the aortic segments rich in plaques in group A1 and A2 respectively. Two weeks later, 10 rabbits each in group A1 and A2 were killed to observe the occurrence rate of spontaneous plaque rupture, and the remaining rabbits in group A1, A2 and B all underwent pharmacological triggering by Chinese Russell's viper venom injected subperitoneally and histamine injected intravenously two times with an interval of 24 hours. Twenty-four hours after the second pharmacological triggering the remaining rabbits were all killed and their abdominal aortae were taken out to undergo macropathologic observation, staining, and immunohistochemistry to examine the accumulation of macrophages and the expression of p53 protein, in the plaques with and without rupture respectively. At the beginning of the experiment and before being killed the serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein choloesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were examined.RESULTS:Before the rabbits were killed the blood-lipid levels were significantly increased in comparison with the baseline levels (all P < 0.01), however, without significant differences among the three groups. The rate of cells positive in p53 transfection was 32.4% +/- 10.2% in the group A1, significantly higher than those in the group A2 and group B (15.8% +/- 3.6% and 16.2% +/- 6.7% respectively, both P < 0.001). The fibrous cap of the plaque was significantly thinner in the group A1 than in the other 2 groups (both P < 0.05). The apoptosis rate was 2.5% +/- 0.8% in the group A1, significantly higher than those in the group A2 and group B (1.0% +/- 0.3% and 0.9% +/- 0.4% respective, both P < 0.01). The accumulation of macrophages within the plaques was significantly remarkable and the number of vessel smooth muscle cells was much smaller in the group A1. Plaque rupture and thrombosis occurred in 12 rabbits, numbering 20 lesions, after pharmacological triggering in the group A1, and occurred in only 5 rabbits, numbering 7 lesions, in the group A2. None of the rabbits in group B showed any lesions after the pharmacological triggering.CONCLUSION:With transfection of human wild-type p53 genes and pharmacological triggering, plaque rupture and thrombosis may occur in most atherosclerotic lesions in rabbits, which offered a reliable model for the further study of unstable plaques.

Dominant‐negative Mutation of Monocyte Chemoattractant Protein‐1 Prevents Vulnerable Plaques from Rupture in Rabbits Independent of Serum Lipid Levels

Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice

Intraplaque injection of Ad5-CMV.p53 aggravates local inflammation and leads to plaque instability in rabbits.

Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.

Oral Rapamycin Attenuates Inflammation and Enhances Stability of Atherosclerotic Plaques in Rabbits Independent of Serum Lipid Levels.

Inhibited Atherosclerotic Plaque Formation by Local Administration of Magnetically Labeled Endothelial Progenitor Cells (epcs) in a Rabbit Model.

NR1D1 Deletion Induces Rupture-Prone Vulnerable Plaques by Regulating Macrophage Pyroptosis Via the NF-κB/NLRP3 Inflammasome Pathway.

Assessment of RANTES levels as the indicators of plaque vulnerability in rabbit models of atherosclerosis.

Specific Matrix Metalloproteinases Play Different Roles in Intraplaque Angiogenesis and Plaque Instability in Rabbits.

Establishing an Animal Model of Unstable Atherosclerotic Plaques

Prediction of Atherosclerotic Plaque Ruptures with High-Frequency Ultrasound Imaging and Serum Inflammatory Markers.

[Induction of Atherosclerotic Plaque Instability in Rabbits after Transfection of Human Wild-Type P53 Gene].

Regulatory T Cells Prevent Plaque Disruption In Apolipoprotein E-Knockout Mice

Relationship Between Lp-PLA_2 and Vulnerable Atherosclerotic Plaque in Rabbits

Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties

Predictors of Vulnerable Atherosclerotic Plaques Induced by Cholesterol and Balloon Injury in Rabbits

Experimental study on induction of atherosclerotic plaque instability in rabbits after transfer of wild-type p53 gene

Prognostic Value of Serum LP-PLA2 and Hs-Crp in Unstable Atherosclerotic Plaques.

Modulating Plaque Inflammation <i>via</i> Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis

Heme Oxygenase-1 Inhibits Progression and Destabilization of Vulnerable Plaques in a Rabbit Model of Atherosclerosis.

Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques.